Semdor Pharma Group
PrivateLast Round
Corporate Funding
Jan 15, 2021
Total Funding Raised
$48.3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Semdor Pharma Group operates in Healthcare & Life Sciences and is based in Cologne. Its latest recorded funding round was a Corporate Funding round in January 2021.
Semdor Pharma Group is a pharmaceutical company that specializes in narcotics and medical cannabis. Formed through the combination of Cannamedical Pharma GmbH and PS Pharma Group, the company provides a broad range of services including the import, handling, packaging, and distribution of narcotic medicines and medical cannabis products to wholesalers, suppliers, and pharmacies across Europe.
Sector
Healthcare & Life Sciences
Verticals
Pharma Supply Chain, Biotechnology, Telemedicine, Compliance, Supply Chain
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Semdor Pharma Group Comparables
Compare Semdor Pharma Group with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SOMAÍ Pharmaceuticals | 83% | |
| Cansativa Group | 81% | |
| DEMECAN | 79% |
For institutional investors. Book with your work email.
Semdor Pharma Group Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Jan 15, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Semdor Pharma Group Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Orkila Capital | Corporate Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 35% MoM, reaching 8.5K.
- Jul 20, 2026
Open roles increased to 20, 95% of headcount.
For institutional investors. Book with your work email.
Semdor Pharma Group Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Semdor Pharma Group's valuation, stock price, and market status.
Is Semdor Pharma Group a public or private company?
Semdor Pharma Group is a private company.
What is the current stock price of Semdor Pharma Group?
Semdor Pharma Group is a private company, so its shares have no public market price. Caplight tracks Semdor Pharma Group's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Semdor Pharma Group worth (valuation)?
Valuation information for Semdor Pharma Group is not publicly available.
Can I buy Semdor Pharma Group stock?
Semdor Pharma Group shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Semdor Pharma Group's last funding round?
Semdor Pharma Group's most recent funding round was Corporate Funding on January 15, 2021.
Who are the main investors in Semdor Pharma Group?
Key investors in Semdor Pharma Group include Orkila Capital.
Will Semdor Pharma Group IPO soon?
No public IPO plans have been announced for Semdor Pharma Group.
How can I track Semdor Pharma Group secondary market activity?
Caplight tracks bids, offers, and trades in Semdor Pharma Group's shares on secondary markets.